Wei-Ping Liu

Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.

Sheng-yu Zhou, Xin Liu, Tao Wu, 2023, Future oncology.

Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study

Y. Chai, S. Qi, Bo Chen, 2023, Annals of hematology.